Custom-tailored strategy against glioblastomas

Glioblastomas are incurable malignant brain tumors. Usually the patients affected survive for only a few months. In addition, every tumor is quite different, which makes treatment very difficult. Researchers have now developed a completely new method as the basis for creating custom-tailored, two-stage therapies. Using tumor samples from a patient, they do lab tests to determine which substances can first make the different types of cancer cells uniform and then effectively kill them.